Moghimi, 2001, Pharmcol Rev., 53, 283
Moghimi, 2000, Trend Biotechnol, 18, 412, 10.1016/S0167-7799(00)01485-2
Woodle, 1992, Biochim Biophys Acta, 1113, 171, 10.1016/0304-4157(92)90038-C
Monfardini, 1998, Bioconjugate Chem., 9, 418, 10.1021/bc970184f
deGennes, 1987, Adv. Colloid Interface Sci., 27, 189, 10.1016/0001-8686(87)85003-0
Moghimi, 1993, Biochim Biophys Acta, 1179, 157, 10.1016/0167-4889(93)90137-E
Lasic, 1991, Biochim Biophys Acta, 1070, 187, 10.1016/0005-2736(91)90162-2
Leon, 1991, J Colloid Interface Sci., 142, 149, 10.1016/0021-9797(91)90043-8
Torchilin, 1994, Biochim Biophys Acta, 1195, 11, 10.1016/0005-2736(94)90003-5
Papisov, 1998, Adv Drug Deliv Rev., 32, 119, 10.1016/S0169-409X(97)00135-X
Dams, 2000, J Pharmcol Exp Ther., 292, 1071
Laverman, 2000, J Pharmcol Exp Ther., 293, 996
Laverman, 2001, Crit Rev Ther Drug Carr Syst, 18, 551, 10.1615/CritRevTherDrugCarrierSyst.v18.i6.40
Moghimi, 1997, Clin Science, 93, 371, 10.1042/cs0930371
Moghimi, 1998, Clin Science, 95, 389, 10.1042/CS19980119
Moghimi, 1993, J Leukoc Biol., 54, 513, 10.1002/jlb.54.6.513
Moghimi, 1996, J Natl Cancer Inst., 88, 766, 10.1093/jnci/88.11.766
Laverman, 2001, Biochim Biophys Acta, 1526, 227, 10.1016/S0304-4165(01)00142-8
Moghimi, 2001, Crit Rev Ther Drug Carr Syst, 18, 527, 10.1615/CritRevTherDrugCarrierSyst.v18.i6.30
Szebeni, 2000, J Liposome Res., 10, 467, 10.3109/08982100009031112
Szebeni, 2002, J Liposome Res., 12, 165, 10.1081/LPR-120004790
Price, 2001, Biochim Biophys Acta, 1512, 191, 10.1016/S0005-2736(01)00330-3
Szebeni, 2001, Crit Rev Ther Drug Carr Syst, 18, 567
Allen, 1994, Trend Pharmacol Sci., 15, 215, 10.1016/0165-6147(94)90314-X
Allen, 1991, Biochim Biophys Acta, 1066, 29, 10.1016/0005-2736(91)90246-5
Utkhede, 1998, J Liposome Res., 8, 537, 10.3109/08982109809039936
Woodle, 1992, Biochim Biophys Acta, 1105, 193, 10.1016/0005-2736(92)90194-Q
Laverman, 2001, J Pharmacol Exp Ther., 298, 607
Chonn, 1992, J Biol Chem., 267, 215, 10.1016/S0021-9258(19)37026-7
Semple, 1995, Biochemistry, 35, 2521, 10.1021/bi950414i
Semple, 1998, Adv Drug Deliv Rev., 32, 3, 10.1016/S0169-409X(97)00128-2
Blunk, 1993, Electrophoresis, 14, 1382, 10.1002/elps.11501401214
Norman ME, Williams P, Illum L. Biomaterials 1992;14:193–202.
Gref, 2000, Colloid Surf B-Biointerf, 18, 301, 10.1016/S0927-7765(99)00156-3
Gref, 1995, Adv Drug deliv Rev., 16, 215, 10.1016/0169-409X(95)00026-4
Stolnik, 2001, Biochim Biophys Acta, 1514, 261, 10.1016/S0005-2736(01)00376-5
Luck, 1999, Electrophoresis, 20, 2063
Peracchia, 1999, Biomaterials, 20, 1269, 10.1016/S0142-9612(99)00021-6
Elwing, 1987, J Biomed Mater Res., 21, 1023, 10.1002/jbm.820210808
Cuypers, 1987, Ann NY Acad Sci., 516, 244, 10.1111/j.1749-6632.1987.tb33045.x
Rapoza, 1988, Poly Mater Sci Eng., 59, 249
Slack, 1995, ACS Symp. Ser., 602, 129, 10.1021/bk-1995-0602.ch009
Bradley, 1998, Arch. Biochem. Biophys., 357, 185, 10.1006/abbi.1998.0798
Szebeni J, Baranyi L, Savay S, Milosevits J, Bodo M, et al. Method Enzymol [in press].
Szebeni, 1999, Circulation, 99, 23022, 10.1161/01.CIR.99.17.2302
Szebeni, 2000, Am. J. Physiol., 279, H1319, 10.1152/ajpcell.2000.279.5.C1319
Mosqueira, 2001, Biomaterials, 22, 2967, 10.1016/S0142-9612(01)00043-6
Gbadamosi, 2002, FEBS Lett., 532, 338, 10.1016/S0014-5793(02)03710-9
Smith, 1982, J Biol Chem., 257, 9879, 10.1016/S0021-9258(18)33952-8
Chonn, 1991, J Immunol., 146, 4234, 10.4049/jimmunol.146.12.4234
Moghimi, 2001, Pharmaceut Res., 18, 1, 10.1023/A:1011054123304
Szebeni, 1998, Crit Rev Ther Drug Carr Syst, 15, 57, 10.1615/CritRevTherDrugCarrierSyst.v15.i1.20
Lutz, 1996, Blood, 88, 184, 10.1182/blood.V88.1.184.184
Bradley, 2001, Transfusion, 41, 1225, 10.1046/j.1537-2995.2001.41101225.x
Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos, D. Pharmacol Rev 51; 1999:691–743.
Wilkinson, 1979, Infec Immun, 23, 502, 10.1128/IAI.23.2.502-508.1979
Gordon, 1986, J Infec Dis, 154, 619, 10.1093/infdis/154.4.619
Cornacoff, 1983, J Clin Invest., 71, 236, 10.1172/JCI110764
Szebeni, 2001, Proc Int Symp Control Rel Bioact Mater., 28
Rodrigueza, 1998, Adv Drug Deliv Rev., 32, 31, 10.1016/S0169-409X(97)00130-0
Moghimi, 2002, Biochim Biophys Acta, 1590, 131, 10.1016/S0167-4889(02)00204-5
Schiffelers, 2001, Pharmaceut Res., 18, 780, 10.1023/A:1011080211226
Abe, 1997, Int J Cancer, 74, 245, 10.1002/(SICI)1097-0215(19970620)74:3<245::AID-IJC2>3.0.CO;2-Z
Vermehren, 1998, Biochim Biophys Acta, 1373, 27, 10.1016/S0005-2736(98)00084-4
Hoyrup, 2001, Biochim Biophys Acta, 1515, 133, 10.1016/S0005-2736(01)00407-2
Davidson, 2003, Biochim Biophys Acta, 1609, 95, 10.1016/S0005-2736(02)00659-4
Eue, 2001, Int J Cancer, 92, 426, 10.1002/ijc.1201
Hunter, 2002, Drug Discov Today, 7, 998, 10.1016/S1359-6446(02)02444-3
Jagannath, 1999, J Interferon Cytokine Res., 19, 67, 10.1089/107999099314432
Hunter, 1984, J Immunol., 133, 3167, 10.4049/jimmunol.133.6.3167
Lloyd, 1996, 361, 10.1007/978-1-4615-5833-0_11
Lloyd, 1998, Clin Science, 95, 107, 10.1042/CS19980026
Washington, 1996, J Phys Chem., 100, 7603, 10.1021/jp953007p
Priev A, Samuni AM, Tirosh O, Barenholz Y. In: Gregoriadis G, McCormack B. Targeting of drugs 6: strategies for stealth therapeutic systems. New York: Plenum Press; 1998. p.147–67
